Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells

Fig. 3

Validation of the custom anti-TK1 antibodies with a TK1 siRNA knockdown experiment in MDA-MB-231 cells. a GAPDH positive, SiRNA negative controls and TK1 siRNA s14160 were tested with commercial anti GAPDH and anti TK1 antibodies. b Validation of 6 custom TK1 antibodies with Western blot analyzing cell lysates from siRNA negative control and TK1 siRNA treated MDA-MB-231 cells. c Normalized TK1 expression in reference to GAPDH and comparison of expression levels between cells treated with TK1 siRNA and untreated

Back to article page